Rohit Joshi
Adelaide Medical School
Faculty of Health and Medical Sciences
Assoc Prof Rohit Joshi MBBS MD FRACP FACP FRCP
A/Prof Rohit Joshi is a Medical Oncology Consultant working at private and public hospitals across Adelaide. He works with the GenesisCare group at Calvary Central Districts Hospital and St Andrew's Hospital. His public Staff Specialist appointment is at the Lyell McEwin Hospital.
He completed his undergraduate and postgraduate training at the Christian Medical College in India, after which he trained in Medical Oncology at the Royal Adelaide Hospital. He also gained European Certification in Medical Oncology in 2012.
Rohit is a Fellow of the Royal Australasian College of Physicians (FRACP), Fellow of the American College of Physicians (FACP), Fellow of the Royal College of Physicians (FRCP) and was certified by the European Society of Medical Oncology (ESMO).
He treats all solid cancer types with major interests in Lung and Breast cancers
Rohit is the Director for Cancer Research SA (CRSA) at St Andrew's. He was the former Director of Research at the Lyell McEwin Hospital and Adelaide Oncology & Haematology. The research includes breast, lung, colorectal, melanoma, head and neck, genitourinary cancers and more; including Phase I (first-in-human), Phase II and Phase III studies. He was the Chairperson of the Adelaide Clinical Trials and Education Consortium (ACTEC), which is supported by Cancer Council SA.
He is actively involved in the teaching and supervision of under-graduate and post-graduate students as an Associate Professor at the University of Adelaide and University of South Australia.
-
Appointments
Date Position Institution name 2020 - ongoing Director Cancer Research SA 2019 - ongoing Adjunct Senior Clinical Fellow University of South Australia 2018 - 2022 Director, Cancer Research Adelaide Oncology and Haematology 2014 - ongoing Consultant, Medical Oncology GenesisCare 2013 - 2017 Director, Cancer Research and Clinical Trials SA Health - Lyell McEwin Hospital 2013 - ongoing Consultant SA Health - Lyell McEwin Hospital 2010 - ongoing Clinical Lecturer University of Adelaide 2008 - 2010 Assistant Professor Christian Medical College -
Language Competencies
Language Competency English Can read, write, speak, understand spoken and peer review Hindi Can read, write, speak and understand spoken Panjabi; Punjabi Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2020 Royal College of Physicians United Kingdom FRCP 2015 American College of Physicians USA FACP 2013 Royal Adelaide and Lyell McEwin Hospitals Australia FRACP 1999 - 2002 Christian Medical College India MD 1991 - 1996 Christian Medical College India MBBS -
Certifications
Date Title Institution name Country 2012 European Certified Medical Oncologist (ECMO) European Society of Medical Oncology Switzerland -
Research Interests
-
Journals
Year Citation 2024 Leighl, N. B., Akamatsu, H., Lim, S. M., Cheng, Y., Minchom, A. R., Marmarelis, M. E., . . . Passaro, A. (2024). Subcutaneous Versus Intravenous Amivantamab, Both in Combination with Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results from the Phase III PALOMA-3 Study. Journal of Clinical Oncology, 42(30), 3593-3605.
Scopus3 Europe PMC12024 Lim, A. H. W., Zobel, J., Bills, M., Hsieh, W., Crouch, B., Joshi, R., . . . Nguyen, N. Q. (2024). The Impact of Combined Chemotherapy and Intra-Tumoural Injection of Phosphorus-32 Microparticles on Vascularity in Locally Advanced Pancreatic Carcinoma. Cancers, 16(19), 14 pages.
2023 Murray, J., Bennett, H., Selva-Nayagam, S., Joshi, R., Bezak, E., & Perry, R. (2023). Impact of Aerobic Training on Cardiovascular Function, Fitness, and Patient Reported Outcomes During Anthracycline Chemotherapy: A Case Series in Women With Breast Cancer. Integrative Cancer Therapies, 22, 13 pages.
2023 Obrocea, M., Seidl, B., Joshi, R., Moore, M., Vitoc, V., Yao, B., & Gryaznov, S. (2023). A phase 2, multi-center, open-label, dose-finding study evaluating telomere targeting agent THIO sequenced with cemiplimab in patients with advanced NSCLC. CANCER RESEARCH, 83(8), 2 pages.
2023 Rainey, N., Joshi, R., Chiu, J., Chen, A., Wang, H., Odegard, J., . . . Adams, S. (2023). A phase 2 randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): ELEVATE-TNBC.. Journal of Clinical Oncology, 41(16_suppl), TPS1130.
2023 Rainey, N., Joshi, R., Chiu, J. W. Y., Chen, A., Wang, H., Odegard, J., . . . Adams, S. (2023). A phase 2, randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer. CANCER RESEARCH, 83(5), 2 pages.
2023 He, K., Carbone, D. P., McKean, M., Balaraman, R., Shah, S., Arrowsmith, E., . . . Li, T. (2023). Safety and clinical activity of target-preserving anti-CTLA-4 antibody ONC-392 as monotherapy in NSCLC patients who progressed on PD(L)1-targeted immunotherapy.. Journal of Clinical Oncology, 41(16_suppl), 9024.
2023 Lee, C. K., Soon, Y. Y., Jeffree, R. L., Joshi, R., Koh, E. S., Lam, W. S., . . . John, T. (2023). Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian Perspective. JTO Clinical and Research Reports, 4(9), 10 pages.
2022 Li, M., Reintals, M., D'Onise, K., Farshid, G., Holmes, A., Joshi, R., . . . Roder, D. M. (2022). Investigating the breast cancer screening-treatment-mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data.. European journal of cancer care, 31(1), 12 pages.
Scopus2 WoS1 Europe PMC12022 Skrabal Ross, X., Gunn, K. M., Suppiah, V., Patterson, P., Boyle, T., Carrington, C., . . . Olver, I. (2022). A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trial. Asia-Pacific Journal of Clinical Oncology, 18(5), e378-e387.
Scopus1 Europe PMC12022 Johnson, M. L., Fox, W., Lee, Y. -G., Lee, K. H., Ahn, H. K., Kim, Y. -C., . . . Joshi, R. (2022). ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant versus zimberelimab in first-line, metastatic, PD-L1-high non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology, 40(36_suppl), 397600.
2022 Yong, C. H., Gupta, A., & Joshi, R. (2022). CSCO breast cancer management guidelines 2022: Australian perspective. TRANSLATIONAL BREAST CANCER RESEARCH, 3, 4 pages.
2022 Telli, M. L., Wapnir, I., Devitt, B., Cuff, K., Soliman, H., Vinayak, S., . . . Joshi, R. (2022). Abstract P2-14-06: Durable responses with intratumoral electroporation of plasmid interleukin-12 plus pembrolizumab in patients with advanced triple-negative breast cancer: Cohort 1 update from KEYNOTE-890. Cancer Research, 82(4_Supplement).
2022 Telli, M., Devitt, B., Cuff, K., Vinayak, S., Nanda, R., Montero, A. J., . . . Joshi, R. (2022). Trial in progress: Phase 2 study of intratumoral plasmid interleukin-12 (tavokinogene telseplasmid; TAVO™) plus electroporation in combination with pembrolizumab with or without chemotherapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (KEYNOTE-890/OMS-I141). CANCER RESEARCH, 82(4), 3 pages.
2021 Alawawdeh, A., Krishnan, T., Roy, A., Karapetis, C., Joshi, R., Singhal, N., & Price, T. (2021). Curative therapy for rectal cancer. Expert Review of Anticancer Therapy, 21(2), 193-203.
Scopus7 WoS5 Europe PMC42021 Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2021). Female breast cancer treatment and survival in South Australia: Results from linked health data.. Eur J Cancer Care (Engl), 30(5), 1-12.
Scopus2 WoS2 Europe PMC22020 Gupta, A., & Joshi, R. (2020). Breast cancer diagnosis and treatment: Asian perspective. TRANSLATIONAL BREAST CANCER RESEARCH, 1, 3 pages.
2020 McCaffrey, N., Asser, T., Fazekas, B., Muircroft, W., Agar, M., Clark, K., . . . Currow, D. C. (2020). Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. BMC Cancer, 20(1), 9 pages.
Scopus9 WoS8 Europe PMC92020 Li, M., Roder, D., D'Onise, K., Walters, D., Farshid, G., Buckley, E., . . . Olver, I. (2020). Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study. BMJ Open, 10(6), e037069.
Scopus4 WoS3 Europe PMC32020 Shepherd, A. R. H., Joshi, R., Tan, C. P., Cohen, P., & Brook, N. R. (2020). Inferior vena cava thrombectomy following complete response to nivolumab/ipilimumab for metastatic renal cell carcinoma. ANZ Journal of Surgery, 90(7-8), 1517-1519.
Scopus7 WoS4 Europe PMC42019 Tan, J. L., Mugwagwa, A. N., Cieslik, L., & Joshi, R. (2019). Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer. BMJ Case Reports, 12(7), 229963-1-229963-5.
Scopus10 WoS7 Europe PMC72019 Roder, D., Karapetis, C. S., Olver, I., Keefe, D., Padbury, R., Moore, J., . . . Price, T. (2019). Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.. BMJ open, 9(9), 1-11.
Scopus24 WoS16 Europe PMC142019 Gupta, A., & Joshi, R. (2019). Improving chemotherapy outcome in early breast cancer. Gland Surgery, 8(5), 585-587.
2019 Parente, P., Chan, B. A., Hughes, B. G. M., Jasas, K., Joshi, R., Kao, S., . . . Stone, E. (2019). Patterns of care for stage III non–small cell lung cancer in Australia. Asia-Pacific Journal of Clinical Oncology, 15(3), 93-100.
Scopus5 WoS4 Europe PMC32018 Townsend, A., Tebbutt, N., Karapetis, C., Cooper, P., Singhal, N., Yeend, S., . . . Price, T. (2018). Phase IB/II study of second-line therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS wild-type metastatic colorectal cancer. Clinical Cancer Research, 24(16), 3838-3844.
Scopus7 WoS5 Europe PMC52018 Adelson, P., Fusco, K., Karapetis, C., Wattchow, D., Joshi, R., Price, T., . . . Roder, D. (2018). Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia. Journal of Evaluation in Clinical Practice, 24(1), 135-144.
Scopus13 WoS12 Europe PMC92017 Currow, D., Watts, G., Johnson, M., McDonald, C., Miners, J., Somogyi, A., . . . Ekström, M. (2017). A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol. BMJ Open, 7(7), e018100-1-e018100-18.
Scopus26 WoS25 Europe PMC152017 Roder, D., Farshid, G., Kollias, J., Koczwara, B., Karapetis, C., Adams, J., . . . Price, T. (2017). Female breast cancer management and survival: the experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly. Journal of Evaluation in Clinical Practice, 23(6), 1433-1443.
Scopus6 WoS5 Europe PMC32017 Aguirre, V. J., Barnett, D., Burdett, N., Joshi, R., & Viana, F. F. (2017). Video-assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy.. Thoracic cancer, 8(4), 363-364.
Scopus2 WoS2 Europe PMC12017 Buckley, E., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Roder, D. (2017). Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model. European Journal of Cancer Care, 26(4), e12673-1-e12673-8.
2017 Roder, D., Farshid, G., Gill, G., Kollias, J., Koczwara, B., Karapetis, C., . . . Beckmann, K. (2017). Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation. Journal of Evaluation in Clinical Practice, 23(3), 508-516.
Scopus4 WoS2 Europe PMC22016 Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2016). Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly. European Journal of Cancer Care, 25(5), 753-763.
Scopus4 WoS4 Europe PMC42016 Beckmann, K. R., Bennett, A., Young, G. P., Cole, S. R., Joshi, R., Adams, J., . . . Roder, D. (2016). Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study. BMC Health Services Research, 16(1), 1-14.
Scopus48 WoS43 Europe PMC272015 Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2015). Colorectal cancer treatment and survival : the experience of major public hospitals in South Australia over three decades. Asian Pacific Journal of Cancer Prevention, 16(6), 2431-2440.
Scopus27 Europe PMC172015 Roder, D., Karapetis, C., Wattchow, D., Moore, J., Singhal, N., Joshi, R., . . . Price, T. (2015). Metastatic colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades. Asian Pacific Journal of Cancer Prevention, 16(14), 5923-5931.
Scopus12 Europe PMC22015 Joshi, R., & Joshi, R. (2015). Deconstructing epidemiology. CHRISMED Journal of Health and Research, 2(1), 3.
2014 Vatandoust, S., Joshi, R., Pitman, K., Esterman, A., Broadbridge, V., Adams, J., . . . Price, T. (2014). A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer. Supportive Care in Cancer, 22(2), 513-518.
Scopus29 WoS24 Europe PMC172013 Butt, S., Vatandoust, S., Kleinig, T., Adams, J., Basu, S., Otto, G., & Joshi, R. (2013). Anti-Ri antibody-associated paraneoplastic brainstem encephalitis successfully treated after treating the underlying malignancy with letrozole. Internal Medicine Journal, 2013(5), 605-606.
Scopus2 WoS22013 Grover, S., Leong, D., Chakrabarty, A., Joerg, L., Kotasek, D., Cheong, K., . . . Selvanayagam, J. (2013). Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers. International Journal of Cardiology, 168(6), 5465-5467.
Scopus95 WoS85 Europe PMC732013 Valsalan, R., Joshi, R., Adams, J., & Arstall, M. (2013). Cardiac failure with bevacizumab: An oversight. Asia Pacific Journal of Clinical Oncology, Online(1), 1-2.
2013 Joshi, R. (2013). Adjuvant colon cancer chemotherapy: is there an Indian standard of care?. South Asian journal of cancer, 2(2), 70-71.
Europe PMC12013 Grover, S., DePasquale, C., Srinivasan, G., Leong, D. P., Chakrabarty, A., Cheong, K. A., . . . Selvanayagam, J. (2013). Contemporary breast cancer chemotherapy leads to persistent late right ventricular myocardial dysfunction: a prospective multi-centre study. Journal of Cardiovascular Magnetic Resonance, 15, P164.
2013 Grover, S., DePasquale, C., Srinivasan, G., Leong, D. P., Chakrabarty, A., Cheong, K. A., . . . Selvanayagam, J. (2013). Early and late left ventricular effects of breast cancer chemotherapy: a prospective multi-centre study using advanced cardiac imaging. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 15(Suppl 1), P142.
Europe PMC12012 Vatandoust, S., Joshi, R., Broadbridge, V., Pittman, K. B., Adams, J., Singhal, N., . . . Price, T. J. (2012). Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study.. Journal of Clinical Oncology, 30(15_suppl), e19513.
2012 Grover, S., DePasquale, C., Leong, D. P., Chakrabarty, A., Cheong, K. A., Kotasek, D., . . . Selvanayagam, J. (2012). Early cardiac changes following anthracycline chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 14(Suppl 1), P181.
Europe PMC12012 Grover, S., De Pasquale, C., Leong, D., Chakrabathy, A., Cheong, K., Kotasek, D., . . . Selvanayagam, J. (2012). Biventricular Ventricular Dysfunction Following Administration of Anthracycline (AC) Chemotherapy In Breast Cancer: A Prospective Multi-Centre Study Using Advanced Cardiac Imaging and Biochemical Markers. Heart, Lung and Circulation, 21, S187.
2012 Vatandoust, S., Joshi, R., & Price, T. (2012). Guillain-Barré syndrome in colorectal cancer. Asia Pacific Journal of Clinical Oncology, 8(2), 205-208.
Scopus4 WoS3 Europe PMC32008 Singhal, N., Hissaria, P., Joshi, R., & Nayagam, S. (2008). Inflammatory myopathy and cancer: Rare association of seminoma testes and polymyositis. Internal Medicine Journal, 38(4), 295-297.
Scopus2 WoS1 Europe PMC22008 Joshi, R., Mammen, K., & Pawar, B. (2008). Successful renal transplantation after two separate urinary tract malignancies. Indian Journal of Urology, 24(2), 256-257.
Scopus3 WoS2 Europe PMC12007 Joshi, R., Olver, I., Keefe, D., Marafioti, T., & Smith, K. (2007). A phase I study to assess the safety and activity of topical lovastatin (FP252S) for the prevention of chemotherapy-induced alopecia. Supportive Care in Cancer, 15(9), 1109-1112.
Scopus7 WoS3 Europe PMC3- Joshi, R., Hocking, C., O’Neill, S., Singhal, N., Kee, M., & Keefe, D. M. (n.d.). A Prospective Audit of Inpatient Medical Oncology Consultation Patterns in a Tertiary Teaching Hospital in South Australia. Global Journal Of Epidemiology and Public Health, 1(2), 42-47.
-
Book Chapters
Year Citation 2018 Joshi, R., & Hong, H. W. (2018). Ascites. In The MASCC Textbook of Cancer Supportive Care and Survivorship (pp. 437-443). Springer International Publishing.
DOI2010 Joshi, R. (2010). Ascites. In The MASCC Textbook of Cancer Supportive Care and Survivorship (pp. 261-265). Springer US.
DOI -
Conference Papers
Year Citation 2022 Ly, Y. J., Hocking, C., Joshi, R., Patel, D., Hong, H., McGregor, M., . . . Kwatra, V. (2022). Real-world comparative data on addition of Atezolizumab to platinum-doublet chemotherapy in extensive stage small cell lung cancer - A single South Australian institution experience. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 18 (pp. 163-164). WILEY. 2022 Ciuleanu, T. -E., Joshi, R., Gryaznov, S., Vitoc, V., & Obrocea, M. (2022). A phase II, multicenter, open-label, dose-finding study evaluating THIO sequenced with cemiplimab in patients with advanced NSCLC. In ANNALS OF ONCOLOGY Vol. 33 (pp. S1094). ELECTR NETWORK: ELSEVIER.
DOI2022 Joshi, R., Goh, J., Joubert, W., Kwarta, V., Okera, M., Bishnoi, S., . . . Gargosky, S. (2022). CLINICAL UPDATE FROM A PHASE 1, FIRST-IN-HUMAN, OPEN-LABEL SINGLE AGENT STUDY OF SUPLEXA THERAPEUTIC CELLS IN PATIENTS WITH METASTATIC SOLID TUMOURS AND HAEMATOLOGIC MALIGNANCIES. In JOURNAL FOR IMMUNOTHERAPY OF CANCER Vol. 10 (pp. A663). BMJ PUBLISHING GROUP.
DOI2022 Hays, J., Li, T., Chen, H., Zahrah, G., Frank, R., Hamm, J., . . . O'Malley, D. (2022). SAFETY AND CLINICAL ACTIVITIES OF THE ACID PH-SENSITIVE ANTI-CTLA-4 MAB ONC-392 IN OVARIAN CANCER PATIENTS. In JOURNAL FOR IMMUNOTHERAPY OF CANCER Vol. 10 (pp. A591). BMJ PUBLISHING GROUP.
DOI2020 Telli, M. L., Wapnir, I., Devitt, B., Cuff, K., Soliman, H., Vinayak, S., . . . Joshi, R. (2020). Phase 2, open-label study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation in combination with intravenous pembrolizumab therapy in patients with inoperable locally advanced or metastatic triple-negative breast cancer (mTNBC) (KEYNOTE-890/OMS-I141). In CANCER RESEARCH Vol. 80 (pp. 3 pages). San Antonio, TX: AMER ASSOC CANCER RESEARCH.
DOI WoS12020 Chan, M. M., Hocking, C., Joshi, R., Patel, D., Singhal, N., McGregor, M., . . . Kwatra, V. (2020). A shift towards virtual multidisciplinary tumour board meeting during COVID 19 pandemic - A South Australian Survey. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 16 (pp. 167). WILEY. 2017 Townsend, A. R., Hardingham, J., Tebbutt, N. C., Karapetis, C. S., Singhal, N., Joshi, R., . . . Price, T. J. (2017). A phase Ib/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT): Biomarker substudy.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35 (pp. 1 page). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.
DOI WoS12015 Patel, D., Abdghan, N., Kerr, K. -A., Row, J., Adams, J., & Joshi, R. (2015). Clinical presentation and management pattern of venous thrombosis in patients receiving chemotherapy. In ANNALS OF ONCOLOGY Vol. 26 (pp. 116-117). Singapore, SINGAPORE: OXFORD UNIV PRESS. 2007 Joshi, R., O'Neill, S., & Keefe, D. (2007). A prospective audit of inpatient medical oncology consultation patterns in a tertiary teaching hospital in South Australia. In ANNALS OF ONCOLOGY Vol. 18 (pp. 196-197). Lugano, SWITZERLAND: OXFORD UNIV PRESS. -
Conference Items
Year Citation 2022 Cilento, M. A., Chalwin, R., Hocking, C., Chan, L., Smithers, L., & Joshi, R. (2022). MORBIDITY AND MORTALITY OF ONCOLOGY PATIENTS ADMITTED TO AN INTENSIVE CARE UNIT. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. 2019 Fernandez-Penas, P., Carlino, M., Atkinson, V., Telli, M., Joshi, R., Thomas, S., . . . Algazi, A. (2019). Intratumoral IL-12 plus pembrolizumab combination therapy in treatment refractory solid tumors: a safety and biomarker analysis. Poster session presented at the meeting of JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMJ PUBLISHING GROUP. 2018 Telli, M., Wapnir, I., Vinayak, S., Soliman, H., Cuff, K., Devitt, B., . . . Joshi, R. (2018). A phase 2 study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation with pembrolizumab in patients with inoperable locally advanced or metastatic triple-negative breast cancer. Poster session presented at the meeting of San Antonio Breast Cancer Symposium. San Antonio, Texas. 2016 Doherty, T., Hislop, C., Fitzgerald, M., Campbell, J., Poprawski, D., Roberts, S., . . . Koczwara, B. (2016). CONTEXT IMPACTS OUTCOMES: LESSONS LEARNT FROM THE SOUTH AUSTRALIAN SURVIVORSHIP FRAMEWORK PILOT IMPLEMENTATION. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY-BLACKWELL. 2016 Townsend, A., Tebbutt, N., Karapetis, C., Cooper, P., Singhal, N., Yeend, S., . . . Price, T. J. (2016). A phase IB/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT). Poster session presented at the meeting of Annals of Oncology. Copenhagen, DENMARK: OXFORD UNIV PRESS.
DOI Scopus1 WoS12016 Joshi, R., Connolly, P., Foo, T., & Rowe, J. (2016). Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy. Poster session presented at the meeting of ANNALS OF ONCOLOGY. OXFORD UNIV PRESS. 2013 Vatandoust, S., Joshi, R., Pittman, K., Esterman, A., Broadbridge, V., Adams, J., . . . Price, T. (2013). A descriptive study of persistent oxaliplatin induced peripheral neuropathy in patients with colorectal cancer. Poster session presented at the meeting of Abstracts of the Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Blood, Biomarkers and Beyond, 31 July - 2 August 2013, as published in Asia-Pacific Journal of Clinical Oncology. Melbourne, Victoria: Wiley-Blackwell.
DOI2013 Townsend, A. R., Pirc, L., Cooper, P., Tebbutt, N. C., Karapetis, C. S., Singhal, N., & Price, T. J. (2013). A phase Ib study of second-line therapy with panitumumab, irinotecan, and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT).. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS.
WoS22012 Grover, S., Depasquale, C., Leong, D., Cheong, K., Kotasek, D., Joshi, R., . . . Selvanayagam, J. (2012). Biventricular dysfunction following administration of anthracycline based chemotherapy in breast cancer: a prospective multi-centre study using advanced cardiac imaging and biochemical markers. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. 2012 Vatandoust, S., Joshi, R., Broadbridge, V., Pittman, K. B., Adams, J., Singhal, N., . . . Price, T. J. (2012). Persistent oxaliplatin (OX) induced peripheral neuropathy in patients (pts) with colorectal cancer: A descriptive study.. Poster session presented at the meeting of JOURNAL OF CLINICAL ONCOLOGY. Chicago, IL: AMER SOC CLINICAL ONCOLOGY. 2011 Cheng, H. B., To, T., Joshi, R., & Singhal, N. (2011). OUTCOMES OF GERIATRIC ASSESSMENT FOR OLDER LUNG CANCER PATIENTS FROM A DEDICATED GERIATRIC ONCOLOGY PROGRAM. Poster session presented at the meeting of JOURNAL OF THORACIC ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
WoS2
Connect With Me
External Profiles